Moberg Pharma AB (MBPH)

Currency in SEK
9.00
-0.01(-0.11%)
Real-time Data·
MBPH Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 8 days
Fair Value
Day's Range
9.009.15
52 wk Range
6.3436.16
Key Statistics
Prev. Close
9.01
Open
9.02
Day's Range
9-9.15
52 wk Range
6.34-36.16
Volume
34.8K
Average Volume (3m)
133.58K
1-Year Change
-73.33%
Book Value / Share
14.68
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MBPH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Moberg Pharma AB Company Profile

Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products primarily in Sweden. It offers MOB-015 for the treatment of nail fungus under the Terclara brand. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. Moberg Pharma AB (publ) was incorporated in 2006 and is based in Bromma, Sweden.

Employees
9
Market
Sweden

Compare MBPH to Peers and Sector

Metrics to compare
MBPH
Peers
Sector
Relationship
P/E Ratio
−1.7x14.3x−0.5x
PEG Ratio
0.000.140.00
Price/Book
0.6x1.9x2.6x
Price / LTM Sales
32.9x1.3x3.3x
Upside (Analyst Target)
21.5%3.6%45.1%
Fair Value Upside
Unlock37.6%7.4%Unlock

Earnings

Latest Release
May 13, 2025
EPS / Forecast
-- / --
Revenue / Forecast
4.00M / --
EPS Revisions
Last 90 days

MBPH Income Statement

FAQ

What Stock Exchange Does Moberg Pharma Trade On?

Moberg Pharma is listed and trades on the Stockholm Stock Exchange stock exchange.

What Is the Stock Symbol for Moberg Pharma?

The stock symbol for Moberg Pharma is "MBPH."

What Is the Moberg Pharma Market Cap?

As of today, Moberg Pharma market cap is 423.95M.

What Is Moberg Pharma's Earnings Per Share (TTM)?

The Moberg Pharma EPS (TTM) is -5.91.

When Is the Next Moberg Pharma Earnings Date?

Moberg Pharma will release its next earnings report on 11 Aug 2025.

From a Technical Analysis Perspective, Is MBPH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Moberg Pharma Stock Split?

Moberg Pharma has split 2 times.

How Many Employees Does Moberg Pharma Have?

Moberg Pharma has 9 employees.

What is the current trading status of Moberg Pharma (MBPH)?

As of 04 Aug 2025, Moberg Pharma (MBPH) is trading at a price of 9.00, with a previous close of 9.01. The stock has fluctuated within a day range of 9.00 to 9.15, while its 52-week range spans from 6.34 to 36.16.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.